INHIBITION OF PSEUDOMONAS-AERUGINOSA VIRULENCE FACTORS BY SUBINHIBITORY CONCENTRATIONS OF AZITHROMYCIN AND OTHER MACROLIDE ANTIBIOTICS

被引:134
作者
MOLINARI, G
GUZMAN, CA
PESCE, A
SCHITO, GC
机构
[1] Institute of Microbiology, Univesity of Genoa, 16132 Genoa
关键词
D O I
10.1093/jac/31.5.681
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The ability of three macrolide antibiotics (erythromycin, clarithromycin and azithromycin) to inhibit the expression of several pathogenicity traits of Pseudomonas aeruginosa at concentrations that do not affect the rate of growth of this micro-organism was investigated. Sub-MICs of azithromycin manifested the broadest spectrum of action and strongly suppressed the synthesis of elastase, proteases, lecithinase and DNase. Clarithromycin and erythromycin were far less effective. Gelatinase was reduced almost to the same level by the three antibiotics, while haemolysins and lipase were only marginally affected. Loss of motility was a strain and drug-dependent event, but all the macrolides tested shared the ability to induce this effect. However, only azithromycin totally suppressed synthesis of pyocyanin in all isolates. These results indicate that newer macrolides and especially azithromycin are endowed with a remarkable ability to inhibit in vitro the expression of a number of physiological processes that are considered more essential than replication in the pathogenesis of P. aeruginosa. Since erythromycin sub-MICs have already been shown to exert beneficial effects in clinical practice, our data, pointing to a much higher potency of azithromycin, suggest its use in future studies. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:681 / 688
页数:8
相关论文
共 24 条
[1]   MOTILITY AND CHEMOTAXIS OF 3 STRAINS OF PSEUDOMONAS-AERUGINOSA USED FOR VIRULENCE STUDIES [J].
CRAVEN, RC ;
MONTIE, TC .
CANADIAN JOURNAL OF MICROBIOLOGY, 1981, 27 (04) :458-460
[2]  
DALHOFF A, 1985, INFLUENCE ANTIBIOTIC, V2, P246
[3]   THE EFFECT OF SUBLETHAL LEVELS OF ANTIBIOTICS ON THE PATHOGENICITY OF PSEUDOMONAS-AERUGINOSA FOR TRACHEAL TISSUE [J].
GEERS, TA ;
BAKER, NR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (05) :569-578
[4]   PHARMACOKINETIC AND INVIVO STUDIES WITH AZITHROMYCIN (CP-62,993), A NEW MACROLIDE WITH AN EXTENDED HALF-LIFE AND EXCELLENT TISSUE DISTRIBUTION [J].
GIRARD, AE ;
GIRARD, D ;
ENGLISH, AR ;
GOOTZ, TD ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
HASKELL, SL ;
RETSEMA, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1948-1954
[5]   INHIBITION OF PSEUDOMONAS-AERUGINOSA EXOENZYME EXPRESSION BY SUBINHIBITORY ANTIBIOTIC CONCENTRATIONS [J].
GRIMWOOD, K ;
TO, M ;
RABIN, HR ;
WOODS, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :41-47
[6]   RESPONSE OF PSEUDOMONAS-AERUGINOSA TO PYOCYANIN - MECHANISMS OF RESISTANCE, ANTIOXIDANT DEFENSES, AND DEMONSTRATION OF A MANGANESE-COFACTORED SUPEROXIDE-DISMUTASE [J].
HASSETT, DJ ;
CHARNIGA, L ;
BEAN, K ;
OHMAN, DE ;
COHEN, MS .
INFECTION AND IMMUNITY, 1992, 60 (02) :328-336
[7]   PSEUDOMONAS-AERUGINOSA ENZYME PROFILING - PREDICTOR OF POTENTIAL INVASIVENESS AND USE AS AN EPIDEMIOLOGICAL TOOL [J].
JANDA, JM ;
BOTTONE, EJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 14 (01) :55-60
[8]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - STRUCTURAL MODIFICATIONS AND INVITRO ACTIVITY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1413-1418
[9]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - PHARMACOKINETICS AND CLINICAL EFFICACY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1419-1422
[10]   SUPPRESSION OF VIRULENCE FACTORS OF PSEUDOMONAS-AERUGINOSA BY ERYTHROMYCIN [J].
KITA, E ;
SAWAKI, M ;
OKU, D ;
HAMURO, A ;
MIKASA, K ;
KONISHI, M ;
EMOTO, M ;
TAKEUCHI, S ;
NARITA, N ;
KASHIBA, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (03) :273-284